Additionally, targeting specific mechanosensitive ion channels, such as TRPM7, Piezo1, or PANX1, may provide new therapeutic strategies for diseases associated with calcium signaling, such as cancer, heart diseases, and inflammation [130,131,132,133,134,135,136]. Here, PIEZO1 is linked to cancer.